rs17216656

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_001972.4(ELANE):​c.655G>A​(p.Val219Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00169 in 1,613,536 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0088 ( 22 hom., cov: 32)
Exomes 𝑓: 0.00095 ( 22 hom. )

Consequence

ELANE
NM_001972.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.301
Variant links:
Genes affected
ELANE (HGNC:3309): (elastase, neutrophil expressed) Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode structurally similar proteins. The encoded preproprotein is proteolytically processed to generate the active protease. Following activation, this protease hydrolyzes proteins within specialized neutrophil lysosomes, called azurophil granules, as well as proteins of the extracellular matrix. The enzyme may play a role in degenerative and inflammatory diseases through proteolysis of collagen-IV and elastin. This protein also degrades the outer membrane protein A (OmpA) of E. coli as well as the virulence factors of such bacteria as Shigella, Salmonella and Yersinia. Mutations in this gene are associated with cyclic neutropenia and severe congenital neutropenia (SCN). This gene is present in a gene cluster on chromosome 19. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a domain Peptidase S1 (size 217) in uniprot entity ELNE_HUMAN there are 55 pathogenic changes around while only 2 benign (96%) in NM_001972.4
BP4
Computational evidence support a benign effect (MetaRNN=0.008954734).
BP6
Variant 19-856015-G-A is Benign according to our data. Variant chr19-856015-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 137201.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-856015-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00885 (1348/152340) while in subpopulation AFR AF= 0.0307 (1277/41570). AF 95% confidence interval is 0.0293. There are 22 homozygotes in gnomad4. There are 635 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1348 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELANENM_001972.4 linkc.655G>A p.Val219Ile missense_variant Exon 5 of 5 ENST00000263621.2 NP_001963.1 P08246

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELANEENST00000263621.2 linkc.655G>A p.Val219Ile missense_variant Exon 5 of 5 1 NM_001972.4 ENSP00000263621.1 P08246
ELANEENST00000590230.5 linkc.655G>A p.Val219Ile missense_variant Exon 6 of 6 5 ENSP00000466090.1 P08246

Frequencies

GnomAD3 genomes
AF:
0.00883
AC:
1344
AN:
152222
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0307
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00366
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00764
GnomAD3 exomes
AF:
0.00225
AC:
564
AN:
250830
Hom.:
7
AF XY:
0.00167
AC XY:
227
AN XY:
135824
show subpopulations
Gnomad AFR exome
AF:
0.0283
Gnomad AMR exome
AF:
0.000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00359
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.000945
AC:
1381
AN:
1461196
Hom.:
22
Cov.:
33
AF XY:
0.000777
AC XY:
565
AN XY:
726900
show subpopulations
Gnomad4 AFR exome
AF:
0.0307
Gnomad4 AMR exome
AF:
0.00105
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00421
Gnomad4 SAS exome
AF:
0.000104
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000162
Gnomad4 OTH exome
AF:
0.00171
GnomAD4 genome
AF:
0.00885
AC:
1348
AN:
152340
Hom.:
22
Cov.:
32
AF XY:
0.00852
AC XY:
635
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.0307
Gnomad4 AMR
AF:
0.00196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00367
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00756
Alfa
AF:
0.00226
Hom.:
6
Bravo
AF:
0.00996
ESP6500AA
AF:
0.0243
AC:
107
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00278
AC:
338
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Oct 07, 2020
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Dec 19, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 20981092, 27884173, 14962902) -

Sep 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cyclical neutropenia;C1859966:Neutropenia, severe congenital, 1, autosomal dominant Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cyclical neutropenia Benign:1
May 28, 2019
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autoinflammatory syndrome Benign:1
Feb 01, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
2.4
DANN
Benign
0.80
DEOGEN2
Uncertain
0.42
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.056
N
LIST_S2
Benign
0.61
.;T
MetaRNN
Benign
0.0090
T;T
MetaSVM
Benign
-0.72
T
MutationAssessor
Benign
0.23
N;N
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.020
.;N
REVEL
Benign
0.28
Sift
Benign
1.0
.;T
Sift4G
Benign
0.98
T;T
Polyphen
0.0030
B;B
Vest4
0.14
MVP
0.43
MPC
0.39
ClinPred
0.00048
T
GERP RS
-1.6
Varity_R
0.11
gMVP
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17216656; hg19: chr19-856015; COSMIC: COSV55047502; COSMIC: COSV55047502; API